technetium tc 99m hydroxymethylene diphosphonate and Kahler Disease

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Kahler Disease in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	5 (55.56)	18.2507
2000's	2 (22.22)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aburano, T; Fujimoto, Y; Kohda, K; Mineta, M; Nagasawa, K; Okizaki, A; Sasaki, T; Takahashi, K	1
Nagai, M; Nishiyama, Y; Ohkawa, M; Satoh, K; Yamamoto, Y	1
Fukumura, T; Ichiya, Y; Kawai, Y; Koga, H; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M	1
Agren, B; Aspelin, P; Måre, K; Rudberg, U	1
Agren, B; Aspelin, P; Björkstrand, B; Lönnqvist, B; Rudberg, U	1
Fig, LM; Gross, MD; Gupta, AK; Meyer, P; Shapiro, B	1
Aktolun, C; Arslan, A; Berk, F; Demir, H; Erdincler, O; Hacihanefioglu, A; Isgoren, S	1
Olson, SP; Posch, TJ	1
Dey, HM; Karimeddini, MK; Spencer, RP; Sziklas, JJ	1

Trials

1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Kahler Disease

Article	Year
Comparative whole-body 201Tl and bone scintigraphies for the detection of bone marrow involvement in multiple myeloma. Nuclear medicine communications, 2003, Volume: 24, Issue:9 Topics: Aged; Antineoplastic Agents; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Thallium; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting	2003

Article

Year

Comparative whole-body 201Tl and bone scintigraphies for the detection of bone marrow involvement in multiple myeloma.

Nuclear medicine communications, 2003, Volume: 24, Issue:9

Topics: Aged; Antineoplastic Agents; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Thallium; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting

2003

Other Studies

8 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Kahler Disease

Article	Year
Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma. Japanese journal of radiology, 2011, Volume: 29, Issue:8 Topics: Aged; Amyloidosis; Female; Humans; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	2011
Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:2 Topics: Adult; Bone Neoplasms; Deoxyglucose; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Ribs; Technetium Tc 99m Medronate; Tomography, Emission-Computed	1993
Bone marrow imaging of bone marrow transplanted multiple myeloma patients. Clinical nuclear medicine, 1997, Volume: 22, Issue:2 Topics: Adult; Antibodies, Monoclonal; Bone and Bones; Bone Marrow; Bone Marrow Transplantation; Bone Neoplasms; Female; Follow-Up Studies; Granulocytes; Humans; Liver; Male; Middle Aged; Multiple Myeloma; Organotechnetium Compounds; Radiography; Radioimmunodetection; Radiopharmaceuticals; Sacrum; Spine; Spleen; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Medronate	1997
Radiography and bone scintigraphy in bone marrow transplant multiple myeloma patients. Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:1 Topics: Adult; Aged; Bone and Bones; Bone Marrow Transplantation; Combined Modality Therapy; Diphosphonates; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Organotechnetium Compounds; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	1997
Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone. Clinical nuclear medicine, 1998, Volume: 23, Issue:12 Topics: Aged; Amyloidosis; Bone and Bones; Bone Neoplasms; Cardiomyopathies; Heart; Humans; Male; Multiple Myeloma; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	1998
Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images. Annals of nuclear medicine, 2002, Volume: 16, Issue:2 Topics: Bone and Bones; Humans; Liver; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon	2002
Marked soft tissue uptake of bone tracer in a patient with amyloidosis and multiple myeloma. Clinical nuclear medicine, 1992, Volume: 17, Issue:11 Topics: Amyloidosis; Bone and Bones; Female; Humans; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Medronate; Tongue	1992
Evaluation of renal-skeleton ratio of technetium-99m phosphonate in multiple myeloma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1985, Volume: 26, Issue:11 Topics: Bone and Bones; Humans; Hypercalcemia; Kidney; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Medronate	1985